This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Baxalta Gmbh, Baxter Healthcare Sa, Baxter International Inc.. Active years: 2014-2016.
Company Filing History:
2 out of 153 
1 out of 1,199 
1 out of 2,531 
Years Active: 2014-2016
Title: Simone Von Fircks: Innovator in Cell Line Production
Introduction
Simone Von Fircks is a prominent inventor based in Vienna, Austria. She has made significant contributions to the field of biotechnology, particularly in the production of continuous cell lines. With a total of 3 patents to her name, her work has the potential to impact various applications in medical and pharmaceutical research.
Latest Patents
One of her latest patents is a method for producing continuous cell lines. This invention involves providing living cells of an animal or a human, irradiating these cells with UV light, proliferating them, and selecting multiplying cells to establish a continuous cell line. Another notable patent is related to substantially animal protein-free recombinant furin and methods for producing the same. This invention focuses on recombinant furin (rFurin) and emphasizes the production of rFurin that is free from animal proteins.
Career Highlights
Throughout her career, Simone has worked with notable companies such as Baxalta GmbH and Nanotherapeutics, Inc. Her experience in these organizations has allowed her to develop innovative solutions that address critical challenges in biotechnology.
Collaborations
Simone has collaborated with esteemed colleagues, including Manfred Reiter and Wolfgang Mundt. These partnerships have fostered a collaborative environment that enhances the development of her inventions.
Conclusion
Simone Von Fircks is a trailblazer in the field of biotechnology, with her innovative patents paving the way for advancements in cell line production. Her contributions are invaluable to the scientific community and hold promise for future research and applications.